The Challenge

A global pharmaceutical corporate strategy team struggled to monitor a rapidly evolving therapeutic landscape using static quarterly reports and siloed, ad-hoc PMR.

They needed a dynamic, unified solution to track competitor clinical trial readouts, identify emerging mechanisms of action, and validate strategic pivots in real-time without inflating their vendor budget.

The Omnitheia Solution

The client deployed Omnitheia’s Integrated Insights platform to modernize their competitive intelligence and transition from reactive reporting to continuous, AI-driven pipeline intelligence.

• Live Data Integration: Omnitheia’s AI continuously monitored clinical trial registries and regulatory filings, instantly flagging unexpected competitor trial accelerations.
  
  
• Predictive Gap Analysis: The client uploaded proprietary clinical reports into our platform. Omnitheia cross-referenced this against all published intelligence and highlighted pipeline assets that would compete with our client’s clinical development. The Evidence Builder generated an initial Confidence Score of 80%, due to these CI gaps in their strategic plan.
  
  
• PMR Intelligence: To assess the true clinical threat, the PMR Intelligence module analysed the competitor’s likely claims and automatically framed the precise probing questions needed to test KOL loyalty to the current standard of care.
  
  
• Expert Validation: Omnitheia’s in-house experts conducted targeted interviews with KOLs to assess switching behaviours. Delivered within 48 hours, these insights validated that the competitor’s new indication would not alter existing prescribing habits.

Impact & Key Results

The corporate strategy team transformed their competitive intelligence workflow, replacing static data with a live, triangulated intelligence hub.

• 30% Reduction in BI Database Spend: Replaced three disjointed, static data subscriptions with one unified platform.
  
  
• 50% Reduction in PMR Turnaround Time: Executed live research within 48 hours to validate a real-time market threat.
  
  
• Proactive Strategic Defence: Successfully tested and neutralised a major competitive threat months ahead of traditional reporting cycles.

Follow Omnitheia on LinkedIn for real-time insights and strategic discussions.